The dual GLP‐1 and GLP‐2 receptor agonist dapiglutide promotes barrier function in murine short bowel
Sign Up to like & getrecommendations! Published in 2022 at "Annals of the New York Academy of Sciences"
DOI: 10.1111/nyas.14791
Abstract: Short bowel syndrome can occur after extensive intestinal resection, causing intestinal insufficiency or intestinal failure, which requires long‐term parenteral nutrition. Glucagon‐like peptide‐2 (GLP‐2) pharmacotherapy is now clinically used to reduce the disease burden of intestinal… read more here.
Keywords: glp; dapiglutide; short bowel; glp glp ... See more keywords